AptarGroup, Inc. (ATR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Loading...
Loading...
Summary:
AptarGroup's fourth-quarter earnings increased 21% year over year to $0.69 share. For 2013, AptarGroup reported record adjusted earnings per share of $2.79, up 10.7% year over year. AptarGroup will benefit from strong momentum in its Pharma business, acquisition of an exclusive global license for Bapco's innovative closure sealing technology and its capacity optimization plan in Europe and further share repurchases. However, continued weakness in the U.S., negative currency exchange and increased resin prices remain headwinds. We, thus, initiate our coverage on AptarGroup with a Neutral recommendation with a target price of $67.


Overview:

Headquartered in Delaware, AptarGroup, Inc. ATR is a global provider of consumer product dispensing systems catering to the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. Products include non-aerosol spray and lotion pumps, plastic dispensing and non-dispensing closures and metered-dose aerosol valves. The company has manufacturing facilities across the globe including North America, Europe, Asia and South America. AptarGroup sells to over 5,000 customers with the largest customer accounting for approximately 6% of its revenue.

AptarGroup's operates through three market-focused business segments - Beauty + Home, Pharma and Food + Beverage.

The Beauty + Home segment consists of operations that sell dispensing systems primarily to the beauty, personal care and home care markets. The segment sells pumps, closures, aerosol valves and accessories to the personal care and home care markets and pumps and decorative components to the beauty market. The segment contributed 59% of AptarGroup's revenues in 2013.

The Pharma segment sells dispensing systems or primary packaging components to the prescription drug, consumer health care and injectables markets. AptarGroup is the leading supplier of pumps and metered dose inhaler valves (MDIs) to the pharmaceutical market worldwide and is the number three supplier of elastomer primary packaging components worldwide. The segment contributed 28% of AptarGroup's revenues in 2013.

The Food + Beverage segment sells dispensing closures and as well as non-dispensing closures, spray pumps and aerosol valves to the food and beverage markets. The segment contributed 13% of AptarGroup's revenues in 2013.

.


AptarGroup, Inc. ATR: Read the Full Research Report

APTARGROUP INC ATR: Free Stock Analysis Report

To read this article on Zacks.com click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...